These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2867526)

  • 1. Inhibition of neurotensin release by a cyclic hexapeptide analog of somatostatin.
    Ferris CF; Parker MC; Armstrong MJ; Leeman SE
    Peptides; 1985; 6(5):945-8. PubMed ID: 2867526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol and fatty acid stimulation of neurotensin release from rat small intestine.
    Ferris CF; Armstrong MJ; George JK; Stevens CA; Carraway RE; Leeman SE
    Endocrinology; 1985 Mar; 116(3):1133-8. PubMed ID: 3971900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and degradation of neurotensin during perfusion of rat small intestine with lipid.
    Ferris CF; Carraway RE; Hammer RA; Leeman SE
    Regul Pept; 1985 Oct; 12(2):101-11. PubMed ID: 3840906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A super active cyclic hexapeptide analog of somatostatin.
    Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG
    Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats.
    Rudholm T; Wallin B; Theodorsson E; Näslund E; Hellström PM
    Regul Pept; 2009 Jan; 152(1-3):8-12. PubMed ID: 18992283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
    Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
    Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of somatostatin, a somatostatin analog, neurotensin and met-enkephalin in the eye with special reference to the irritative response.
    Stjernschantz J; Sears ML; Oksala O
    J Ocul Pharmacol; 1985; 1(1):59-70. PubMed ID: 2906080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin stimulates [3H]oleic acid translocation across rat small intestine.
    Armstrong MJ; Parker MC; Ferris CF; Leeman SE
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G823-9. PubMed ID: 3789148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromedin-N is not released with neurotensin from rat ileum.
    Cuber JC; Herrmann C; Kitabgi P; Bosshard A; Bernard C; De Nadai F; Chayvialle JA
    Endocrinology; 1990 Mar; 126(3):1584-92. PubMed ID: 2307120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoneutralization of somatostatin and neurotensin: effect on gastric acid secretion.
    Seal A; Liu E; Buchan A; Brown J
    Am J Physiol; 1988 Jul; 255(1 Pt 1):G40-5. PubMed ID: 2898896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats.
    Hammer RA; Ochoa A; Fernandez C; Ertan A; Arimura A
    Peptides; 1992; 13(6):1175-9. PubMed ID: 1362980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in neurotensin-like immunoreactivity in rat plasma after administration of calcium, bombesin and fat and its inhibition by somatostatin.
    Rökaeus A
    Acta Physiol Scand; 1984 Nov; 122(3):261-7. PubMed ID: 6151337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin levels in the hepatic-portal circulation are inversely related to the circadian feeding cycle in rats.
    George JK; Albers HE; Carraway RE; Ferris CF
    Endocrinology; 1987 Jul; 121(1):7-13. PubMed ID: 3595525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal bile salts and neurotensin release in the isolated vascularly perfused rat jejuno-ileum.
    Dakka T; Dumoulin V; Chayvialle JA; Cuber JC
    Endocrinology; 1994 Feb; 134(2):603-7. PubMed ID: 8299558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.